Proof of Usefulness Report

Proove Genomics Inc.

Analysis completed on 2/16/2026

+28
Proof of Usefulness Score
You're In Business

Proove Genomics is a controversial pharmacogenomics company attempting a relaunch (July 2024) following a 2017 collapse, FBI raids, and a 2023 dismissal of criminal charges against its founder. While the company possesses a significant historical dataset (153k patients), the submission contains blatantly false claims (e.g., 'most people have used my product', audience is 'everyone') and confusing metrics ('all time marketcap'). The scientific validity of its tests has been historically questioned by experts (e.g., STAT News investigations). The low score reflects the severe credibility gap in the submission and the 'restarting' nature of the business despite its historical scale.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+40.0
Audience Reach Impact+5.0
Technical Innovation+50.0
Evidence Of Traction+10.0
Market Timing Relevance+70.0
Functional Completeness+5.0
Subtotal+28.25
Usefulness Multiplierx1.01
Final Score+29

Project Details

Project URL
Description
Proove Genomics is a predictive healthcare and personalized medical diagnostics company. Our predict and prevent approach to precision medicine is supported by the world's largest clinical data bank, which includes data from over 153,000 pain patients and encompasses 28 billion clinical outcome data points. Proove conducts laboratory testing that utilizes advanced information technology and mathematical algorithms in its CLIA-certified laboratory, coupled with a patient’s phenotypic factors such as age, gender, and ethnicity, we enhance the treatment of pain and other ailments for improved patient quality of life. Our research has been published in peer-reviewed journals and recognized by leading medical societies such as the American Academy of Pain Medicine, American Society of Interventional Pain Physicians, American Academy of Neurology, American Society of Regional Anesthesia, American Academy of Addiction Medicine, and more. Proove operates a state-of-the-art CLIA-certified laboratory in the Dallas-Forth Worth Metroplex. Proove is also opening offices in southern California, the Baltimore-Washington metropolitan area, and the Salt Lake City metropolitan area.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline